Coverage gains are at risk from Medicaid unwinding and expiring ACA tax credits; in 43 states Hispanic adults most often ...

Oncology pharmacists can operationalize payer-mediated transitions such as biosimilar adoption, minimizing clinician burden while reducing waste and total cost of care. Earlier CAR T-cell therapy ...

Bridging academic and community oncology requires formal communication pathways, shared education/research infrastructure, ...

Overcoming Early Barriers to Care’, Brandi Jones led the conversation about the following questions: How old were you when ...

Nail psoriasis affects a significant proportion of patients with psoriasis, but it represents one of the disease's most ...

Rose Gerber, MS, director of patient advocacy and education at the Community Oncology Alliance (COA) Patient Advocacy Network ...

Karen Fancher, PharmD, BCOP, associate professor of pharmacy practice at Duquesne University and clinical oncology specialist ...

Advanced therapies are pressuring reimbursement and necessitating real-world durability data and new payment models, said ...

A pragmatic cluster-randomized trial across 8 CHC sites (Boston and Los Angeles) enrolled 5127 adults aged 45–75 years overdue for screening, randomizing clinics to FIT versus FIT-DNA outreach.

Adoption metrics show a wide gap between declared AI priority and production deployment in health care, compounded by limited ...

Lekan Ajayi, PharmD, explains how remote therapy monitoring keeps patients with cancer on track with their care and reduces ...

Innovations in pharmacy are already delivering results, but there is still work to do to evolve the ecosystem, said Ryan ...